Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
CONCLUSIONS: In this study, DDRT was not associated with an inferior OS compared to SDRT in patients with HPV-positive OPSCC. Randomized clinical trials to address DDRT in this patient population are currently ongoing.
PMID: 31005228 [PubMed - in process]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Gabani P, Lin AJ, Barnes J, Oppelt P, Adkins DR, Rich JT, Zevallos JP, Daly MD, Gay HA, Thorstad WL Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Databases & Libraries | Genital Warts | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Radiation Therapy | Radiology | Science | Skin Cancer | Squamous Cell Carcinoma | Study